Revision history of "Preclinical and clinical development of first class, innovative bispecific immunotherapy as a candidate for cancer immunotherapy" (Q77985)

13 October 2024

• curprev 05:5305:53, 13 October 2024‎ DG Regio talk contribs‎ 90,445 bytes −24‎ ‎Changed label, description and/or aliases in pt
• curprev 05:5305:53, 13 October 2024‎ DG Regio talk contribs‎ 90,469 bytes −88‎ ‎Set a claim value: summary (P836): O objetivo deste projeto é desenvolver o primeiro formato proteico biespecífico de classe, inovador, seguro e clinicamente eficaz (VHH/VH, SCFV ou Fab), permitindo visar tanto a via de resposta imunitária PD-1/PD-L1 como recetores selecionados do fator de crescimento, e a sua validação em ensaios clínicos de Fase I e II como um candidato para utilização em terapia tumoral sólida. Serão gerados candidatos inovadores com base na tecnologia Phage Displ...

7 March 2024

• curprev 14:1314:13, 7 March 2024‎ DG Regio talk contribs‎ 90,557 bytes +288‎ ‎Added qualifier: readability score (P590521): 0.7188943158175342

12 January 2024

• curprev 16:1116:11, 12 January 2024‎ DG Regio talk contribs‎ 90,269 bytes +1,083‎ ‎Changed an Item

11 June 2023

• curprev 11:0911:09, 11 June 2023‎ Admin talk contribs‎ 89,186 bytes +435‎ BatchIngestion

24 May 2023

• curprev 16:5816:58, 24 May 2023‎ DG Regio talk contribs‎ 88,751 bytes +949‎ ‎Changed an Item

3 March 2023

• curprev 00:3500:35, 3 March 2023‎ DG Regio talk contribs‎ 87,802 bytes +1,805‎ ‎Changed label, description and/or aliases in it, da, sk, ga, et, fi, de, bg, hr, lv, es, pt, cs, fr, nl, hu, ro, lt, sl, el, mt, sv, and other parts

25 October 2022

• curprev 10:5110:51, 25 October 2022‎ DG Regio talk contribs‎ 85,997 bytes +841‎ ‎Changed an Item: Import item from Poland

19 October 2022

• curprev 22:3522:35, 19 October 2022‎ DG Regio talk contribs‎ 85,156 bytes +1,226‎ ‎Changed an Item: Import item from Poland
• curprev 22:3522:35, 19 October 2022‎ DG Regio talk contribs‎ 83,930 bytes −419‎ ‎Removed claim: co-financing rate (P837): 61.22 percentage
• curprev 22:3522:35, 19 October 2022‎ DG Regio talk contribs‎ 84,349 bytes −411‎ ‎Removed claim: instance of (P35): Discontinued Kohesio Project (Q4412041)
• curprev 22:3422:34, 19 October 2022‎ DG Regio talk contribs‎ 84,760 bytes −5‎ ‎Changed an Item: Continued project

17 October 2022

• curprev 15:4415:44, 17 October 2022‎ DG Regio talk contribs‎ 84,765 bytes +416‎ ‎Changed an Item: Discontinued project

25 July 2022

• curprev 19:5719:57, 25 July 2022‎ DG Regio talk contribs‎ 84,349 bytes +54,220‎ ‎Changed label, description and/or aliases in da, el, hr, ro, sk, mt, pt, fi, sl, cs, lt, lv, bg, hu, ga, sv, et, nl, fr, de, it, es, and other parts: Adding translations: da, el, hr, ro, sk, mt, pt, fi, sl, cs, lt, lv, bg, hu, ga, sv, et,

19 January 2022

• curprev 11:1411:14, 19 January 2022‎ DG Regio talk contribs‎ 30,129 bytes +3,073‎ ‎Changed label, description and/or aliases in es, and other parts: Adding Spanish translations

15 January 2022

• curprev 22:1622:16, 15 January 2022‎ DG Regio talk contribs‎ 27,056 bytes +2,916‎ ‎Changed label, description and/or aliases in it, and other parts: Adding Italian translations

16 December 2021

• curprev 19:1619:16, 16 December 2021‎ DG Regio talk contribs‎ 24,140 bytes +2,994‎ ‎Changed label, description and/or aliases in nl, and other parts: Adding Dutch translations

7 December 2021

• curprev 08:1408:14, 7 December 2021‎ DG Regio talk contribs‎ 21,146 bytes +2,981‎ ‎Changed label, description and/or aliases in de, and other parts: Adding German translations

30 November 2021

• curprev 14:3114:31, 30 November 2021‎ DG Regio talk contribs‎ 18,165 bytes +2,971‎ ‎Created claim: summary (P836): L’objectif de ce projet est de mettre au point un format protéique bispécifique de première classe, innovant, sûr et cliniquement efficace (VHH/VH, scFv ou Fab) afin de cibler les voies de réponse immunitaire PD-1/PD-L1 et certains récepteurs des facteurs de croissance, et sa validation dans les essais cliniques de phase I et de phase II comme candidat à une utilisation dans le traitement des tumeurs solides. Des candidats innovants seront génér...
• curprev 14:3114:31, 30 November 2021‎ DG Regio talk contribs‎ 15,194 bytes +230‎ ‎Changed label, description and/or aliases in fr: translated_label

29 October 2020

• curprev 04:4404:44, 29 October 2020‎ DG Regio talk contribs‎ 14,964 bytes −406‎ ‎Removed claim: financed by (P890): Directorate-General for Regional and Urban Policy (Q8361), Removing unnecessary financed by statement
• curprev 04:4404:44, 29 October 2020‎ DG Regio talk contribs‎ 15,370 bytes −34‎ ‎Changed label, description and/or aliases in 2 languages: Changing unique label-description pair

14 October 2020

• curprev 10:5110:51, 14 October 2020‎ DG Regio talk contribs‎ 15,404 bytes +188‎ ‎Changed label, description and/or aliases in 1 language: translated_label
• curprev 10:5110:51, 14 October 2020‎ DG Regio talk contribs‎ 15,216 bytes −194‎ ‎Changed label, description and/or aliases in 1 language: remove_english_label
• curprev 10:5110:51, 14 October 2020‎ DG Regio talk contribs‎ 15,410 bytes +2,628‎ ‎Created claim: summary (P836): The aim of this project is to develop the first in class, innovative, safe and clinically effective bispecific protein format (VHH/VH, SCFV or Fab), allowing for targeting both the immune response pathway PD-1/PD-L1 and selected growth factor receptors, and its validation in Phase I and II clinical trials as a candidate for use in solid tumour therapy. Innovative candidates will be generated on the basis of Phage Display technology and immunisat...
• curprev 10:5110:51, 14 October 2020‎ DG Regio talk contribs‎ 12,782 bytes −2,162‎ ‎Removed claim: summary (P836): The aim of this project is to develop the first class, innovative, safe and effective clinically specific protein format (VHH/VH, scFv or Fab), allowing targeting both in the PD-1/PD-L1 pathway and selected drivers of the growth factors, and its validation in clinical trials I and II as a candidate per medicine for treating solid tumours.Innovative candidates will be generated on the basis of the Phage Display and immunisation techniques to se...

25 September 2020

• curprev 00:1700:17, 25 September 2020‎ DG Regio talk contribs‎ 14,944 bytes +1,161‎ ‎Changed an Item: Fixing rounding issue
• curprev 00:1700:17, 25 September 2020‎ DG Regio talk contribs‎ 13,783 bytes −1,162‎ ‎Removed claim: budget (P474): 10,481,966.052 euro

23 September 2020

• curprev 04:3504:35, 23 September 2020‎ DG Regio talk contribs‎ 14,945 bytes +1,160‎ ‎Changed an Item: Fixing rounding issue
• curprev 04:3504:35, 23 September 2020‎ DG Regio talk contribs‎ 13,785 bytes −1,162‎ ‎Removed claim: EU contribution (P835): 6,416,621.0664 euro

15 July 2020

• curprev 18:2218:22, 15 July 2020‎ DG Regio talk contribs‎ 14,947 bytes +431‎ ‎Changed an Item

9 June 2020

• curprev 15:2715:27, 9 June 2020‎ DG Regio talk contribs‎ 14,516 bytes +429‎ ‎Changed an Item

6 June 2020

• curprev 20:4720:47, 6 June 2020‎ DG Regio talk contribs‎ 14,087 bytes +431‎ ‎Changed an Item

26 March 2020

• curprev 10:1810:18, 26 March 2020‎ DG Regio talk contribs‎ 13,656 bytes +431‎ ‎Changed an Item

4 March 2020

• curprev 08:5508:55, 4 March 2020‎ DG Regio talk contribs‎ 13,225 bytes +2,162‎ ‎Created claim: summary (P836): The aim of this project is to develop the first class, innovative, safe and effective clinically specific protein format (VHH/VH, scFv or Fab), allowing targeting both in the PD-1/PD-L1 pathway and selected drivers of the growth factors, and its validation in clinical trials I and II as a candidate per medicine for treating solid tumours.Innovative candidates will be generated on the basis of the Phage Display and immunisation techniques to sele...

18 February 2020

• curprev 07:0807:08, 18 February 2020‎ DG Regio talk contribs‎ 11,063 bytes +194‎ ‎Changed an Item: Label in wikidata changed

8 February 2020

• curprev 15:5715:57, 8 February 2020‎ DG Regio talk contribs‎ 10,869 bytes +823‎ ‎Changed an Item
• curprev 15:5715:57, 8 February 2020‎ DG Regio talk contribs‎ 10,046 bytes −417‎ ‎Removed claim: financed by (P890): European Union (Q1)

31 January 2020

• curprev 15:5015:50, 31 January 2020‎ DG Regio talk contribs‎ 10,463 bytes +1,348‎ ‎Changed an Item
• curprev 15:5015:50, 31 January 2020‎ DG Regio talk contribs‎ 9,115 bytes −844‎ ‎Removed claims
• curprev 09:4809:48, 31 January 2020‎ DG Regio talk contribs‎ 9,959 bytes +844‎ ‎Changed an Item

13 January 2020

• curprev 20:5720:57, 13 January 2020‎ DG Regio talk contribs‎ 9,115 bytes +9,115‎ ‎Created a new Item